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Two simple, sensitive, and selective spectrophotometric methods for the determination of 5-
(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)benzoic acid (furosemide, FUR) are described.
The methods are based on acid hydrolysis of FUR to free primary aromatic amine and dia-
zotization followed by coupling with N-1-napthylethylene diamine (NEDA) (method A) or 4,5-
dihydroxynaphthalene-2,7-disulfonic acid (chromotropic acid, CTA) (method B). The colored reac-
tion product can be measured spectrophotometrically at 520 nm (method A) or 500 nm (method B).
Beer’s law is obeyed over the ranges of 1.75–21.0 µg mL−1 and 2.5–30.0 µg mL−1, for method A and
method B, respectively. Apparent molar absorptivities and Sandell’s sensitivities (in L mol−1 cm−1
and µg cm−2 per 0.001 absorbance unit, respectively) were 1.34 × 104 and 0.0253 using NEDA
as the coupling agent, and 8.5 × 103 and 0.0389 using CTA for the same purpose. Analysis of
solutions containing seven diﬀerent concentrations of FUR gave a correlation coeﬃcient of 0.9979
using NEDA and 0.9984 using CTA, while the slope and the correlation coeﬃcient of the regression
equation were calculated. The reaction stoichiometry in both methods was evaluated by the limiting
logarithmic method and was found to be 1 : 1 (diazotized FUR: NEDA or diazotized FUR: CTA).
The methods were successfully applied to the determination of FUR in spiked human urine and in
pharmaceutical formulations. The recovery of FUR from spiked urine was satisfactory resulting in
the values of (109.4 ± 4.37) % using NEDA and (113.0 ± 4.74) % using CTA. Results of the analysis
of pharmaceuticals demonstrated that the proposed procedures are at least as accurate and precise
as the oﬃcial method while a statistical analysis indicated that there was no signiﬁcant diﬀerence
between the results obtained by the proposed methods and those of the oﬃcial method.
c© 2010 Institute of Chemistry, Slovak Academy of Sciences
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Introduction
Furosemide (FUR), chemically known as 5-(amino-
sulfonyl)-4-chloro-2-[(2-furanylmethyl)amino] benzoic
acid (Fig. 1), is a potent diuretic. It is used to
treat excessive ﬂuid accumulation and swelling of the
body caused by heart failure, cirrhosis, chronic kid-
ney failure, and nephritic syndrome. The association
of FUR and N-amidino-3,5-diamino-6-chloropyrazine-
carboxamide hydrochloride (amiloride hydrochloride,
AMU) furnishes a valuable natriuretic agent with a
weaker kaliuretic eﬀect, minimizing the risk of al-
kalosis in the treatment of refractory edema associ-
ated with hepatic cirrhosis or congestive heart fail-
ure (Martindale: The extra pharmacopoeia, 1989).
Owing to its extensive use as a powerful diuretic,
FUR has long attracted the attention of many an-
alysts. A variety of analytical methods for the de-
termination of FUR in biological ﬂuids and phar-
maceutical samples have been proposed; the meth-
ods published in the nineties and up to 2007 have
been reviewed by Espinosa Bosch et al. (2008). Of-
ﬁcial methods for the determination of FUR in
dosage forms are based on titrimetry (European Di-
*Corresponding author, e-mail: basavaiahk@yahoo.co.in
416 K. Tharpa et al./Chemical Papers 64 (4) 415–423 (2010)
O
HO
S O
NH2
O
Cl
HN
O
NaNO2/H2SO4
O
HO
S O
NH2
O
Cl
N
O
N
O
H
H
O
HO
S O
NH2
O
Cl
N
O
Oxidation
O
HO
S O
NH2
O
Cl
HN
O
O
A
cid
 
h y
dr
ol
ys
is
O
HO
S O
NH2
O
Cl
NH2
COOH
O
+
O
HO
S O
NH2
O
Cl
N +
N
Nitrosation product,
Diazotization, RT
NHCH2CH2NH2
+
NHCH2CH2NH2NN
OHO
Cl
S
O
OH2N
Method
 AMet
hod 
B
SO3NaNaO3S
OH OH
+
SO3NaNaO3S
OH OH
Coupling Coupling
Furosemide
Chromotropic acid
N-napthylethylene diame
NN
HO O
Cl
S
O
OH2N
Fig. 1. Probable reaction pathway.
rectorate for the Quality of Medicines, 2001), spec-
trophotometry (The United States Pharmacopoeia,
2000), and HPLC (The British Pharmacopoeia Com-
mission, 2002). Many techniques for the determina-
tion of FUR in pharmaceuticals or in biological ma-
trix are available, they include UV spectrophotome-
try (Tescarollo Dias et al., 2005), spectroﬂuorimetry
(Llorent-Martínez et al., 2005; Ioannou et al., 1998;
Semaan et al., 2008), high performance liquid chro-
matography (HPLC) with UV detection (Jankowski et
al., 1997), HPLC with ﬂuorescence detection (Gomez
et al., 2005; Reeuwijk et al., 1992; Abou-Auda et al.,
1998), HPLC with amperometric detection (Guzmán
et al., 2003), HPLC-DAD (Semaan et al., 2005a),
LC-MS (Abdel-Hamid, 2000), GC-MS (Ptáček et al.,
1996), micellar-LC (Carda-Broch et al., 2002), ratio-
spectra derivative spectroscopy (Millership et al.,
2005), and diﬀuse reﬂectance spectroscopy (Gotardo
et al., 2004).
Some of these methods suﬀer from interference
from the tablet matrix, whereas others are time-
consuming or require expensive equipment and are
consequently not suitable for routine analysis, partic-
ularly in developing and under developed countries.
From the above, the need for a fast, low-cost and se-
lective method seems clearly apparent. Visible spec-
trophotometry continues to fulﬁll the above deﬁned
requirements. Quite a few visible spectrophotmetric
methods (Živanovic´ et al., 1990; Go¨lcu¨, 2006; Semaan
et al., 2005b; Semaan & Cavalheiro, 2006; Basavaiah
et al., 2005; Sevillano-Cabeza et al., 1997; García et
al., 1997; Mishra et al., 1990; Shah et al., 2005; Sastry
et al., 1988, 1989; Issopoulos, 1989) have been devel-
oped for the quantiﬁcation of FUR in pharmaceuti-
